Datapoint: Oklahoma Supreme Court Nixes Medicaid Managed Care
The Oklahoma Supreme Court on June 1 ruled that the state’s public health agency cannot implement a managed care program as part of the state’s upcoming Medicaid expansion. In the original suit, the Oklahoma Sta...
Datapoint: FDA Approves First Once-Daily Uterine Fibroids Drug
The FDA on May 25 approved Myovant Sciences’ and Pfizer’s Myfembree for the treatment of heavy menstrual bleeding caused by uterine fibroids in premenopausal women. In a Phase 3 trial, women taking Myfembree saw...
Datapoint: United Dominates Medicare OEP
Medicare Advantage enrollment grew by 257,093 lives during the 2021 Open Enrollment Period (OEP), according to AIS’s Directory of Health Plans. As in the Annual Election Period (AEP), UnitedHealthcare dominated th...
Datapoint: Philadelphia Health System to Gain 100% Ownership of Health Partners Plans
Philadelphia-based health system Jefferson Health is set to gain 100% ownership of Health Partners Plans, according to a report in the Philadelphia Business Journal. The 18-hospital system, a unit of Thomas Jefferso...
Datapoint: Blue Shield of California Program Sees $20 Million in Rx Savings
Blue Shield of California last week said its partnership with tech company Gemini Health has resulted in $20 million of drug cost savings in its first two years. The initiative supplies Blue Shield-affiliated provid...
Datapoint: Mission Health Joins Blue Cross NC’s Value-Based Care Program
Mission Health on Monday joined Blue Cross and Blue Shield of North Carolina’s Blue Premier value-based care program, making it the 11th health system to do so. The agreement goes live Jan. 1, 2022, and Mission He...
Datapoint: J&J’s Rybrevant Approved in NSCLC
Following a priority review, the FDA on May 21 approved Johnson & Johnson’s Rybrevant for the treatment of non-small cell lung cancer in patients with epidermal growth factor receptor (EGFR) Exon 20 Insertio...
Datapoint: Bright Health Files for IPO
Following the trend of startup insurers going public, Bright Health last week filed a registration statement for a proposed IPO. The number of initial shares and their price range has not been determined. Bright Hea...
Datapoint: Apellis Pharmaceuticals to Take on Alexion in PNH
The FDA on May 14 approved Apellis Pharmaceuticals’ Empaveli as a first-line treatment for paroxysmal nocturnal hemoglobinuria (PNH), a rare and deadly chronic blood disorder. The biotech said it will initially ta...
Datapoint: Alignment Healthcare Sees $57 Million Loss in 1Q21
In its first quarter as a publicly traded company, startup Medicare Advantage insurer Alignment Healthcare reported a $56.9 million loss. Founder and CEO John Kao said the company exceeded expectations. As of May 20...